Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Perindopril And Indapamide (Excluding Perindopril As Arginine Salt), Atc C09Ba54 For The Period 01.02.25 - 31.01.27

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 99894618

  Document Type - Tender Notices

Description - Description: Section 130a Paragraph 8 SGB V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for medicines dispensed at the expense of statutory health insurance companies. In view of the relev ant statutory provisions for the award of public contracts, DAK-Gesundheit carries out a regular process of active ingredient-related, formal award procedures in accordance with the provisions of Part 4 of the GWB. For medicines containing the above-mentioned active ingredient, perindopril and indapamide (only perindopril as arginine salt), ATC C09BA54, which are to be named by the bidder in Annex 2 to the contract, DAK-Gesundheit intends to conc

Gt Ref Id - 99894618

Deadline - Dec 04, 2026